AL
DPLO

Airain Ltd’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Airain Ltd’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,179
Closed -$206K – 1141
2015
Q3 		$206K Sell
7,179
-4,890
-41% -$209K 0.01% 701
2015
Q2 		$540K Buy
+12,069
New +$454K 0.03% 503

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Airain Ltd's DPLO Position: Q4 2015 in Review

Airain Ltd sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2015, closing a stake of 7,179 shares — an estimated $206K sold.

Airain Ltd first reported a position in DPLO in Q2 2015 and held it in 2 quarters. The position peaked at $540K in Q2 2015. 151 funds tracked by Wall St. Rank hold DPLO as of Q4 2015.

  • Airain Ltd reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2015 after selling out during the quarter.
  • Airain Ltd sold 7,179 DIPLOMAT PHARMACY, INC. shares in Q4 2015, an estimated $206K.
  • Airain Ltd first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 2 quarters.
  • Airain Ltd's DIPLOMAT PHARMACY, INC. position peaked at $540K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2015.

Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.